Jasper Therapeutics, Inc.

JSPR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$71,637$86,887$38,250$84,701
Short-Term Investments$0$0$0$0
Receivables$0$250$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,174$1,801$3,481$3,130
Total Curr. Assets$75,811$88,938$41,731$87,831
Property Plant & Equip (Net)$2,851$4,194$5,454$4,833
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$417$417$0$0
Tax Assets$0$0$0$0
Other NC Assets$820$1,343$1,176$990
Total NC Assets$4,088$5,954$6,630$5,823
Other Assets$0$0$0$0
Total Assets$79,899$94,892$48,361$93,654
Liabilities
Payables$4,027$4,149$1,768$3,919
Short-Term Debt$1,089$972$865$505
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$10,121$7,253$4,432$3,596
Total Curr. Liab.$15,237$12,374$7,065$8,020
LT Debt$724$1,814$2,786$2,380
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,264$2,264$2,521$13,736
Total NC Liab.$2,988$4,078$5,307$16,116
Other Liabilities$0$0$0$0
Cap. Leases$1,813$2,786$3,651$2,885
Total Liabilities$18,225$16,452$12,372$24,136
Equity
Pref Stock$0$0$0$0
Common Stock$2$1$0$4
Retained Earnings-$240,869-$169,600-$105,135-$67,450
AOCI$0$0$0$0
Other Equity$302,541$248,039$141,124$136,964
Total Equity$61,674$78,440$35,989$69,518
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$79,899$94,892$48,361$93,654
Net Debt-$69,824-$84,101-$34,599-$81,816